atovaquone has been researched along with Immunologic Deficiency Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, AJ; Belperron, AA; Ben Mamoun, C; Bockenstedt, LK; Boulard, P; Bruzual, I; Doggett, JS; Forquer, IP; Garg, A; Hinrichs, DJ; Kumar, V; Lawres, LA; Mao, J; Nilsen, A; Pou, S; Preston, DA; Renard, I; Riscoe, MK; Rodriguez, EX; Virji, AZ; Wegmann, KW; Winter, RW | 1 |
| Häselbarth, K; Hunfeld, KP; Krieger, G; Kurz, M | 1 |
2 other study(ies) available for atovaquone and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.
Topics: Animals; Atovaquone; Babesia microti; Babesiosis; Immunologic Deficiency Syndromes; Mice; Mice, SCID; Prodrugs; Quinolones | 2016 |
[Babesiosis in an immunocompromised German patient].
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antineoplastic Agents; Atovaquone; Azithromycin; Babesiosis; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Lymphoma, B-Cell; Male; Middle Aged; Opportunistic Infections; Rituximab; Splenectomy | 2008 |